ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1771

Arterial Thrombotic Events in Systemic Vasculitis

Alexander Tsoukas1, Sasha Bernatsky2, Lawrence Joseph3, David Buckeridge4, Patrick Belisle5 and Christian A. Pineau1, 1Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 2Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 3McGill University, Montreal, QC, Canada, 4Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada, 5Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Comorbidity, systemic vasculitides and thrombosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose

To estimate the incidence rate of clinically apparent arterial thrombotic events and associated comorbidities in patients with primary systemic vasculitis.

Methods

Using large-cohort administrative data from Quebec, Canada, we identified all patients with vasculitis, including those with polyarteritis nodosa and granulomatosis with polyangiitis. Incident myocardial infarctions and cerebrovascular events after the diagnosis of vasculitis were ascertained longitudinally via billing and hospitalization data and compared to rates of a general population comparator group. The incidences of comorbidities (DMII, dyslipidemia, and hypertension) were also collected.

Results

Among the 836 patients identified with vasculitis, the myocardial infarction event rate was substantially higher in younger patients, with rates up to 268.1 events per 10,000 pt years [95% CI 67.1-1070.2] in males aged 18-45 with polyarteritis nodosa, approximately 30 times that seen in the age- and sex-matched control group. The cerebrovascular event rate was also substantially higher, particularly in adults aged 45-65 regardless of vasculitis type. All patient groups with vasculitis had elevated incidences of diabetes, dyslipidemia and hypertension compared to the general population.

Conclusion

Atherothrombotic event rates were elevated in patients identified as having primary systemic vasculitis. While incident rates of cardiovascular comorbidities were also increased, the substantial elevation in myocardial infarctions seen in young adults suggests a disease-specific component which requires further investigation.


Disclosure:

A. Tsoukas,
None;

S. Bernatsky,
None;

L. Joseph,
None;

D. Buckeridge,
None;

P. Belisle,
None;

C. A. Pineau,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/arterial-thrombotic-events-in-systemic-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology